What about a stock that is reduced from a 1 from 3 chance to show it had a product that works. Turning into a 0 out of 3 chance of something working?
That's as good a reason I can think of for a 141 Million dollar company which has no viable product, to be re-rated at next to nothing.
If this trial ( Lets call it - the trial that could not fail ) - Fails to repeat what it showed on a petri - dish , after failing with Acne, after failing with Atopic Dermatitis........ the only thing they have consistently demonstrated is they can bamboozle us with good looking pre-clinical stats, and not manage to turn anything into reality when it comes to testing with people......
Ann: Trading Halt, page-189
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |